Clinical Trials Browser

Not yet recruiting × NETWORK × Plasma cell × Clear all

NCT07085728 2025-08-22

Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure

Phase 2 Not yet recruiting

Multiple Myeloma

NCT07107529 2025-08-12

Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

Phase 2 Not yet recruiting

Multiple Myeloma

NCT05944783 2025-02-12

BE-Dasatinib

Phase 4 Not yet recruiting

Multiple Myeloma